November 8, 2024 - Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2024
September 24, 2024 - Revelation Biosciences’ Gemini Induces Dose Dependent Significant Increases in IL-10
August 21, 2024 - Revelation Biosciences Inc. Announces Exercise of Warrants for $3.8 Million in Gross Proceeds
August 9, 2024 - Revelation Biosciences, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2024
